N-[2,6-dibromo-4-(trifluoromethoxy)phenyl]-2-methylsulfonyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide
C13H6Br2F6N2O4S2 — CID 141449776
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2,6-dibromo-4-(trifluoromethoxy)phenyl]-2-methylsulfonyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide
N-[2,6-dibromo-4-(trifluoromethoxy)phenyl]-2-methylsulfonyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide (PubChem CID 141449776) has the molecular formula C13H6Br2F6N2O4S2 and a molecular weight of 592.13 g/mol. Its IUPAC name is N-[2,6-dibromo-4-(trifluoromethoxy)phenyl]-2-methylsulfonyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide.
Molecular Properties
| Compound Name | N-[2,6-dibromo-4-(trifluoromethoxy)phenyl]-2-methylsulfonyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide |
|---|---|
| PubChem CID | 141449776 |
| Molecular Formula | C13H6Br2F6N2O4S2 |
| Molecular Weight | 592.13 g/mol |
| Exact Mass | 589.80 |
| IUPAC Name | N-[2,6-dibromo-4-(trifluoromethoxy)phenyl]-2-methylsulfonyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide |
| SMILES | CS(=O)(=O)c1nc(C(F)(F)F)c(C(=O)Nc2c(Br)cc(OC(F)(F)F)cc2Br)s1 |
| InChI | InChI=1S/C13H6Br2F6N2O4S2/c1-29(25,26)11-23-9(12(16,17)18)8(28-11)10(24)22-7-5(14)2-4(3-6(7)15)27-13(19,20)21/h2-3H,1H3,(H,22,24) |
| InChIKey | WGPVOWLPVVTXFX-UHFFFAOYSA-N |
| XLogP | 5.24 |
| TPSA | 85.36 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 592.13 |
| LogP ≤ 5 | 5.24 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141449776 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.